Financial statements Biogene
Balance sheet of Biogene
Company age:
Age:
14 y. 7 m. 9 d.
Share capital:
Share capital:
5 000 PLN
Balance sheet data of BIOGENE
|
Year
|
2020
|
2021
|
2022
|
|---|---|---|---|
| Total assets | 1 103 767,70 | 1 096 382,62 | 1 752 886,90 |
| A. Fixed assets | 693 951,80 | 730 302,38 | 1 276 893,68 |
| B. Current assets | 409 815,90 | 366 080,24 | 475 993,22 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | 0,00 | 0,00 | 0,00 |
| Total liabilities | 1 103 767,70 | 1 096 382,62 | 1 752 886,90 |
| A. Equity | -339 111,89 | -56 754,46 | -130 938,46 |
| B. Liabilities and provisions for liabilities | 1 442 879,59 | 1 153 137,08 | 1 883 825,36 |
| I. Long-term liabilities | 562 255,52 | 335 220,98 | 686 077,34 |
| II. Short-term liabilities | 876 638,76 | 817 916,10 | 1 197 748,02 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.